Inflectra 100 mg powder for concentrate for solution for infusion

Licence status
Authorised: 10/09/2013
Active substances
Ct-p13 (infliximab)
Dosage Form
Powder for concentrate for solution for infusion
Licence number
EU/1/13/854/001-005
Licence holder
Pfizer Europe MA EEIG

Product documents

Licence information

ATC code
L04AB Tumor necrosis factor alpha (TNF-) inhibitors, L04AB02 infliximab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
10/09/2013

Educational materials for patients